Ethical and Legal Implications of the SARS-CoV-2 Response Strategy (PATA 4: Observation-04 )

Health
1

Observation-04 - Transparency Failures and Data Manipulation in U.S. SARS-CoV-2 Response Reporting

Substandard Reporting Systems:

  • Design Flaws: If reporting systems like VAERS are designed in a way that leads to under-reporting or obfuscation, this could indeed be intentional or at least negligent, especially when dealing with public health on such a scale in the United States.

  • Improvement Need: There’s a clear call for:

    • Enhanced Reporting Mechanisms: Active surveillance systems that proactively seek out data, rather than relying on passive reporting.
    • Standardization: Nationally consistent reporting standards to allow for better comparison and analysis across different states and systems.
    • Transparency: Full disclosure of data, including raw data for independent analysis, and clear methodologies for how data are collected and interpreted.

Data Manipulation and Record Deletion:

  • Manipulation of Data: There have been allegations of data manipulation, including instances where records were deleted[5] or details omitted, particularly with the CDC’s reporting systems, which only came to light through FOIA requests4. Such actions undermine public trust and the integrity of health data, necessitating stringent measures to prevent future occurrences.

  • Military Record Keeping: Whistleblower testimony suggests that there might have been tampering with vaccine injury data within military systems, highlighting a critical area where oversight and transparency are severely lacking1.

Recommendations for Preventive Measures:

  • Blockchain Technology for Decentralized Record Keeping:

    • Immutable Records: Propose the use of blockchain technology to ensure records are tamper-proof, providing an immutable ledger of all reported data that can be publicly verified but not altered.
    • Decentralization: This would decentralize control over data, reducing the risk of manipulation by any single entity and ensuring that data integrity is maintained through consensus mechanisms.

  • Enhanced Whistleblower Protections:

    • Strengthen legal protections for whistleblowers to encourage the reporting of data manipulation or ethical breaches within health reporting systems, ensuring those who expose wrongdoing are not penalized but rewarded for their transparency.

  • Independent Audits: Regular, independent audits of reporting systems by bodies with no financial or political stake in the outcomes to verify the accuracy and integrity of the data.

Case Studies and Testimonies:

  • Military Data Tampering: Whistleblower claims from within the U.S. military suggest systematic manipulation of vaccine injury data, as reported by Sharyl Attkisson1.

  • Reporting System Critique: Dr. Tenpenny’s analysis of the current reporting system points to significant flaws and possible corruption in how adverse events are documented and reported2.

  • Legal Insights: Attorney Thomas Renz’s release of data from a lesser-known vaccine injury and death tracking system underscores the need for transparency and reform in how such critical health data is managed3.

  • CDC’s VAERS Safety Monitoring: The CDC’s reluctance to disclose full safety monitoring data until compelled by FOIA requests highlights systemic issues in transparency and data management within the agency4.

Conclusion:

The manipulation and lack of transparency in data related to public health interventions like the SARS-CoV-2 response necessitate immediate action to restore trust, integrity, and accountability in U.S. reporting systems. By implementing blockchain technology, enhancing whistleblower protections, and ensuring independent oversight, we can begin to address these critical issues.

Footnotes

[1]: U.S. Military Whistleblowers’ Claims
[2]: Dr. Tenpenny on Reporting System Issues
[3]: Attorney Thomas Renz on Vaccine Injury Data
[4]: CDC’s VAERS Safety Monitoring Disclosure
[5]: Critical Appraisal of VAERS Pharmacovigilance: Is the U.S. Vaccine Adverse Events Reporting System (VAERS) a Functioning Pharmacovigilance System? - Rose J. Science, Public Health Policy and the Law. 2021 Oct 01; v3.2019-2024

Out of Votes? Answer this Poll!

  • 100% Agree
  • Mostly agree, but with reservations
  • Half agree/disagree
  • Mostly disagree, but agree with some of this
  • 100% Disagree
0 voters

If you disagree with this proposal or have reservations, explain your reasoning and what should be changed where, and why. This will help to refine the proposal for a greater consensus.